{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:29:30Z","timestamp":1707524970368},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,10]]},"DOI":"10.7759\/cureus.37383","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T16:09:40Z","timestamp":1681142980000},"source":"Crossref","is-referenced-by-count":0,"title":["De-escalation of Sentinel Lymph Node Biopsy in Patients With Ductal Carcinoma In Situ"],"prefix":"10.7759","author":[{"given":"Hussain A","family":"Abdulla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmeen","family":"Khalaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-021-01225-0","article-title":"Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study","volume":"28","author":"Tanaka K","year":"2021","unstructured":"Tanaka K, Masuda N, Hayashi N, et al.. Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study. Breast Cancer. 2021, 28:896-903. 10.1007\/s12282-021-01225-0","journal-title":"Breast Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v7.i2.258","article-title":"Sentinel lymph node biopsy in clinically detected ductal carcinoma in situ","volume":"7","author":"Al-Ameer AY","year":"2016","unstructured":"Al-Ameer AY, Al Nefaie S, Al Johani B, et al.. Sentinel lymph node biopsy in clinically detected ductal carcinoma in situ. World J Clin Oncol. 2016, 7:258-64. 10.5306\/wjco.v7.i2.258","journal-title":"World J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.13737","article-title":"Sentinel lymph node positivity in patients undergoing mastectomies for ductal carcinoma in situ (DCIS)","volume":"26","author":"Price A","year":"2020","unstructured":"Price A, Schnabel F, Chun J, et al.. Sentinel lymph node positivity in patients undergoing mastectomies for ductal carcinoma in situ (DCIS). Breast J. 2020, 26:931-6. 10.1111\/tbj.13737","journal-title":"Breast J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0030","article-title":"Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Gradishar WJ","year":"2022","unstructured":"Gradishar WJ, Moran MS, Abraham J, et al.. Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022, 20:691-722. 10.6004\/jnccn.2022.0030","journal-title":"J Natl Compr Canc Netw"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2006.05.013","article-title":"Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial","volume":"13","author":"Wilke LG","year":"2006","unstructured":"Wilke LG, McCall LM, Posther KE, et al.. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006, 13:491-500. 10.1245\/ASO.2006.05.013","journal-title":"Ann Surg Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano AE","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, et al.. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011, 305:569-75. 10.1001\/jama.2011.90","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343","volume":"31","author":"Hughes KS","year":"2013","unstructured":"Hughes KS, Schnaper LA, Bellon JR, et al.. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013, 31:2382-7. 10.1200\/JCO.2012.45.2615","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2023.01.002","article-title":"Omission of axillary sentinel lymph node biopsy in early invasive breast cancer","volume":"67","author":"Reimer T","year":"2023","unstructured":"Reimer T. Omission of axillary sentinel lymph node biopsy in early invasive breast cancer. Breast. 2023, 67:124-8. 10.1016\/j.breast.2023.01.002","journal-title":"Breast"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16134","article-title":"When is sentinel lymph node biopsy useful in ductal carcinoma in situ? The experience at a Latin American cancer center","volume":"13","author":"Diaz Casas SE","year":"2021","unstructured":"Diaz Casas SE, Serrano Mu\u00f1oz WA, Buelvas G\u00f3mez NA, et al.. When is sentinel lymph node biopsy useful in ductal carcinoma in situ? The experience at a Latin American cancer center. Cureus. 2021, 13:e16134. 10.7759\/cureus.16134","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.35735","article-title":"Upgrade rate of ductal carcinoma in situ to invasive carcinoma and the clinicopathological factors predicting the upgrade following a mastectomy: a retrospective study","volume":"15","author":"Al-Ishaq Z","year":"2023","unstructured":"Al-Ishaq Z, Hajiesmaeili H, Rahman E, Khosla M, Sircar T. Upgrade rate of ductal carcinoma in situ to invasive carcinoma and the clinicopathological factors predicting the upgrade following a mastectomy: a retrospective study. Cureus. 2023, 15:e35735. 10.7759\/cureus.35735","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4476-5","article-title":"The role of sentinel lymph node biopsy and factors associated with invasion in extensive DCIS of the breast treated by mastectomy: the cinnamome prospective multicenter study","volume":"22","author":"Tunon-de-Lara C","year":"2015","unstructured":"Tunon-de-Lara C, Chauvet MP, Baranzelli MC, et al.. The role of sentinel lymph node biopsy and factors associated with invasion in extensive DCIS of the breast treated by mastectomy: the cinnamome prospective multicenter study. Ann Surg Oncol. 2015, 22:3853-60. 10.1245\/s10434-015-4476-5","journal-title":"Ann Surg Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2012.06.012","article-title":"Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision","volume":"21","author":"Kim J","year":"2012","unstructured":"Kim J, Han W, Lee JW, et al.. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. Breast. 2012, 21:641-5. 10.1016\/j.breast.2012.06.012","journal-title":"Breast"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31815b446b","article-title":"Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years","volume":"247","author":"Intra M","year":"2008","unstructured":"Intra M, Rotmensz N, Veronesi P, et al.. Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years. Ann Surg. 2008, 247:315-9. 10.1097\/SLA.0b013e31815b446b","journal-title":"Ann Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-016-3783-2","article-title":"Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy","volume":"156","author":"van Roozendaal LM","year":"2016","unstructured":"van Roozendaal LM, Goorts B, Klinkert M, et al.. Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy. Breast Cancer Res Treat. 2016, 156:517-25. 10.1007\/s10549-016-3783-2","journal-title":"Breast Cancer Res Treat"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-018-0871-7","article-title":"Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy","volume":"25","author":"Watanabe Y","year":"2018","unstructured":"Watanabe Y, Anan K, Saimura M, et al.. Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy. Breast Cancer. 2018, 25:663-70. 10.1007\/s12282-018-0871-7","journal-title":"Breast Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2004.11.012","article-title":"Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ","volume":"200","author":"Yen TW","year":"2005","unstructured":"Yen TW, Hunt KK, Ross MI, et al.. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg. 2005, 200:516-26. 10.1016\/j.jamcollsurg.2004.11.012","journal-title":"J Am Coll Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2014.15.1.55","article-title":"Factors predicting microinvasion in ductal carcinoma in situ","volume":"15","author":"Ozkan-Gurdal S","year":"2014","unstructured":"Ozkan-Gurdal S, Cabioglu N, Ozcinar B, et al.. Factors predicting microinvasion in ductal carcinoma in situ. Asian Pac J Cancer Prev. 2014, 15:55-60. 10.7314\/apjcp.2014.15.1.55","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2021.11.018","article-title":"De-escalating axillary surgery in early-stage breast cancer","volume":"62 Suppl 1","author":"Hersh EH","year":"2022","unstructured":"Hersh EH, King TA. De-escalating axillary surgery in early-stage breast cancer. Breast. 2022, 62 Suppl 1:S43-9. 10.1016\/j.breast.2021.11.018","journal-title":"Breast"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.1274","article-title":"Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen","volume":"28","author":"Dowsett M","year":"2010","unstructured":"Dowsett M, Cuzick J, Ingle J, et al.. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol. 2010, 28:509-18. 10.1200\/JCO.2009.23.1274","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2012.06.013","article-title":"Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND)","volume":"21","author":"Gentilini O","year":"2012","unstructured":"Gentilini O, Veronesi U. Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND). Breast. 2012, 21:678-81. 10.1016\/j.breast.2012.06.013","journal-title":"Breast"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20670","article-title":"Sentinel lymph node biopsy is feasible even after total mastectomy","volume":"95","author":"Intra M","year":"2007","unstructured":"Intra M, Veronesi P, Gentilini OD, et al.. Sentinel lymph node biopsy is feasible even after total mastectomy. J Surg Oncol. 2007, 95:175-9. 10.1002\/jso.20670","journal-title":"J Surg Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-13064-0","article-title":"Delayed sentinel lymph node dissection in patients with a preoperative diagnosis of ductal cancer in situ by preoperative injection with superparamagnetic iron oxide (SPIO) nanoparticles: the sentinot study","author":"Karakatsanis A","year":"2023","unstructured":"Karakatsanis A, Eriksson S, Pistiolis L, et al.. Delayed sentinel lymph node dissection in patients with a preoperative diagnosis of ductal cancer in situ by preoperative injection with superparamagnetic iron oxide (SPIO) nanoparticles: the sentinot study. Ann Surg Oncol. 2023, 10.1245\/s10434-022-13064-0","journal-title":"Ann Surg Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/149681-de-escalation-of-sentinel-lymph-node-biopsy-in-patients-with-ductal-carcinoma-in-situ","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:00Z","timestamp":1707508680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/149681-de-escalation-of-sentinel-lymph-node-biopsy-in-patients-with-ductal-carcinoma-in-situ"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,10]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.37383","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,10]]}}}